KMS Medisurgi Limited has announced a board meeting to discuss related party transactions disclosure.

Since the company is listed on the BSE SME platform and meets specific criteria on paid-up equity and net worth, it is not required to disclose related party transactions for the year ending March 31, 2025. This exemption reduces compliance disclosure requirements, potentially lowering administrative burdens for the company and providing clarity to shareholders on reporting obligations.